Clinical Trials
All Clinical Trials - Page 50 of 52
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT00225420Phase 1/Phase 2Completed
Docetaxel, Androgen Ablation, and External-Beam Radiation Therapy in Patients With High-Risk Localized Prostate Cancer
Gonadorelin
- NCT01508806Phase 1Completed
Safety and Tolerability of Liraglutide in Subjects With Impaired Kidney Function and in Subjects With Normal Kidney Function
Liraglutide
- NCT00228943N/ACompleted
The Role of Serotonin in Hot Flashes After Breast Cancer
KPV
- NCT00123253Phase 3Completed
TH9507 in Patients With HIV-Associated Lipodystrophy
Tesamorelin
- NCT01076335Phase 2Completed
Neoadjuvant Hormones + Docetaxel in Node-Positive Prostate Cancer
Gonadorelin
- NCT00796458Phase 3Unknown
Androgen Ablation With or Without Docetaxel in Treating Patients With Advanced Prostate Cancer
Gonadorelin
- NCT00196846Phase 2Completed
Prevention of Chemotherapy Induced Ovarian Failure With Goserelin in BC Patients (ZORO)
Gonadorelin
- NCT00161421Phase 2Completed
Oral Androgens in Man-3 (ORAL T-3) Pharmacokinetics of Oral Testosterone
Gonadorelin
- NCT00296465Phase 2/Phase 3Completed
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Three Dosage Strengths of Pulsatile GnRH
Gonadorelin
- NCT00103935Phase 2Completed
Study Examining Exenatide Long-Acting Release in Subjects With Type 2 Diabetes
Exenatide
- NCT01514487Phase 1Completed
Comparison of Three Liraglutide Formulations in Healthy Volunteers
Liraglutide
- NCT00800930Phase 2Completed
Therapeutic Induction of Endogenous Antibiotics
Ll-37
- NCT01037699Phase 3Completed
Luteinizing Hormone (LH) Supplementation in Gonadotropin-releasing Hormone (GnRH) Antagonist Cycles
Gonadorelin
- NCT00154401Phase 2Completed
Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes
Liraglutide
- NCT00154414Phase 2Completed
Effect of Liraglutide on Blood Glucose Control in Japanese Subjects With Type 2 Diabetes
Liraglutide
- NCT00517283Phase 1Completed
A Study by Scintigraphy to Evaluate the Effect of Exenatide on Gastric Emptying in Subjects With Type 2 Diabetes
Exenatide
- NCT01178996Phase 3Completed
Thymosin Alpha-1 in Combination With Peg-Interferon Alfa- 2a and Ribavirin for the Therapy of Chronic Hepatitis C Nonresponsive to the Combination of IFN and Ribavirin.
Thymosin-Alpha-1
- NCT00566813Phase 1/Phase 2Completed
Islet Transplantation in Type 1 Diabetic Patients Using the Edmonton Protocol of Steroid Free Immunosuppression
Exenatide
- NCT00293696Phase 4Completed
Casodex/Zoladex Biomarkers in Localised Prostate Cancer
Gonadorelin
- NCT00197860Phase 1/Phase 2Completed
Dendritic Cell Based Therapy of Renal Cell Carcinoma
Thymosin-Alpha-1
- NCT01077323N/ACompleted
A Retrospective Cohort Study of Acute Pancreatitis in Relation to Use of Exenatide and Other Antidiabetic Agents
Exenatide
- NCT00097500Phase 3Completed
Effects of Exenatide and Insulin Glargine in Subjects With Type 2 Diabetes
Exenatide
- NCT00099619Phase 3Completed
Comparing Exenatide and Insulin Glargine in Type 2 Diabetes Patients for Whom Insulin is the Next Appropriate Therapy
Exenatide
- NCT00349258Phase 4Completed
The Use of GnRH Agonist Trigger in the Prevention of OHSS
Gonadorelin
- NCT00458458Phase 3Unknown
Treatment of Endometriosis With Norethindrone Acetate ( NA) VS. Gonadotropin- Releasing Hormone (GnRH) Agonist (Lupron Depot 11.25 mg)
Gonadorelin
- NCT00081159Phase 2Completed
Hormone Ablation Therapy, Doxorubicin, and Zoledronate With or Without Strontium 89 in Treating Patients With Androgen-Dependent Prostate Cancer and Bone Metastases
Gonadorelin
- NCT01069094Phase 1/Phase 2Completed
A Study of Progenta (CDB-4124) in Pre-menopausal Women With Symptomatic Leiomyomata
Gonadorelin
- NCT01081873N/ACompleted
Study to Document Treatment Patterns and to Evaluate Leuprolide and Alternative Therapeutic Approaches to the Treatments of Advanced Prostate Cancer
Gonadorelin
- NCT00170157Phase 2Completed
Hormone Therapy and Ipilimumab in Treating Patients With Advanced Prostate Cancer
Gonadorelin
- NCT01508897Phase 1Completed
Comparison of Two Liraglutide Formulations in Healthy Volunteers
Liraglutide
- NCT00099320Phase 3Completed
Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using Thiazolidinediones or Thiazolidinediones and Metformin
Exenatide
- NCT01011751Phase 3Completed
Treatment of Hot Flushes Caused by Leuprorelin 11.25 mg in Prostate Adenocarcinoma
Gonadorelin
- NCT01507337Phase 1Completed
Comparison of the Effect of Liraglutide in Young Versus Elderly Healthy Volunteers
Liraglutide
- NCT00791843Phase 2Completed
The Effect of GHRH Therapy on Myocardial Structure and Function in Congestive Heart Failure
Sermorelin
- NCT00412022Phase 3Unknown
HOBOE: A Phase 3 Study of Adjuvant Triptorelin and Tamoxifen, Letrozole, or Letrozole and Zoledronic Acid in Premenopausal Patients With Breast Cancer.
Gonadorelin
- NCT00075192Phase 1/Phase 2Completed
CP-675,206 With Neoadjuvant Hormone Therapy in Patients With High Risk Prostate Cancer
Gonadorelin
- NCT00099333Phase 2Completed
Study of the Safety of Substituting Exenatide for Insulin in Patients Using Insulin and Oral Antidiabetic Agents
Exenatide
- NCT01060488Phase 3Completed
Comparative Validation of the Growth Hormone Releasing Hormone and Arginine Test for the Diagnosis of Adult Growth Hormone Deficiency
Sermorelin
- NCT01764230N/ACompleted
Prevention of Ovarian Function Damage by a GnRH Analogue During Chemotherapy in Hodgkin Lymphoma Patients
Gonadorelin
- NCT00066690Phase 3Completed
Suppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
Gonadorelin
- NCT00076440Phase 2Completed
Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation (ALADDIN) VP 104 Study
Gonadorelin
- NCT01615978Phase 1Completed
Safety and Tolerability of Liraglutide in Japanese Subjects With Type 2 Diabetes
Liraglutide
- NCT01876849Phase 3Completed
An Open-Label Study Examining the Long-Term Safety of Exenatide Given Twice Daily to Patients With Type 2 Diabetes Mellitus
Exenatide
- NCT00082407Phase 3Completed
Exenatide Compared With Twice-Daily Biphasic Insulin Aspart in Patients With Type 2 Diabetes Using Sulfonylurea and Metformin
Exenatide
- NCT00193856Phase 3Completed
RADAR Trial - Randomised Androgen Deprivation and Radiotherapy
Gonadorelin
- NCT00311636Phase 3Completed
Triptorelin in Preventing Early Menopause in Premenopausal Women Who Are Receiving Chemotherapy for Stage I, Stage II, or Stage III Breast Cancer That Has Been Removed By Surgery
Gonadorelin
- NCT00203996Phase 4Terminated
Polycystic Ovary Syndrome (PCOS) and Sleep Apnea
Gonadorelin
- NCT01620476Phase 1Completed
Safety and Tolerability of Liraglutide in Healthy Japanese Volunteers
Liraglutide
- NCT00085969Phase 2Completed
Effect of Exenatide Monotherapy on Glucose Control in Subjects With Type 2 Diabetes Mellitus
Exenatide
- NCT00587431Phase 2Completed
Docetaxel With Rapid Hormonal Cycling as a Treatment for Patients With Prostate Cancer
Gonadorelin